Clinical trials
Terminated Atherosclerosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
71 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2004 | 4 |
| 2005 | 4 |
| 2006 | 5 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 3 |
| 2010 | 7 |
| 2011 | 7 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 71 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbott Medical Devices | 3 |
| National Heart, Lung, and Blood Institute (NHLBI) | 3 |
| Organon and Co | 3 |
| Brigham and Women's Hospital | 2 |
| Imperial College London | 2 |
| National Institute on Aging (NIA) | 2 |
| University of Calgary | 2 |
| Vanderbilt University | 2 |
| Abbott Products | 1 |
| Algemeen Ziekenhuis Maria Middelares | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atherosclerosis | 71 |
| Cardiovascular Diseases | 15 |
| Coronary Artery Disease | 15 |
| Inflammation | 9 |
| Hypercholesterolemia | 8 |
| Coronary Disease | 6 |
| Myocardial Infarction | 6 |
| Stroke | 6 |
| Peripheral Arterial Disease | 5 |
| Heart Diseases | 4 |
Trials
Showing 76 to 71 of 71. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.